Etanercept Therapy for Psoriasis in a Patient with Numerous Comorbidities

被引：2
|
作者：
De Simone, Clara [1 ]
Carbone, Angelo [1 ]
Caldarola, Giacomo [1 ]
机构：
[1] Policlin Univ, I-00168 Rome, Italy
来源：
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY | 2010年 / 11卷
关键词：
IDIOPATHIC DILATED CARDIOMYOPATHY; NECROSIS-FACTOR-ALPHA; EXPRESSION;
D O I：
10.2165/1153425-S0-000000000-00000
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
A recent study demonstrated an association between psoriasis and dilated cardiomyopathy. Tumour necrosis factor alpha (TNF alpha) may be involved in the pathogenesis of dilated cardiomyopathy and therefore, anti-TNF alpha agents may play a role in the treatment of dilated cardiomyopathy. The case of a 51-year-old woman with severe psoriasis and numerous comorbidities including dilated cardiomyopathy is described. During treatment with etanercept, the patient's psoriasis improved rapidly without any worsening of her other conditions. Etanercept was safe and effective in the treatment of severe psoriasis in a patient with numerous comorbidities, including dilated cardiomyopathy.
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [21] Psoriasis: Pathogenesis, Comorbidities, and Therapy Updated
    Kanda, Naoko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (06)
  • [22] A comprehensive omics assessment of etanercept therapy for psoriasis
    Foulkes, A.
    Rattray, N.
    Pirmohamed, M.
    Goodacre, R.
    Reynolds, N. J.
    Donaldson, M. J.
    Barnes, M.
    Griffiths, C. E.
    Warren, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S32 - S32
  • [23] Intermittent etanercept therapy in pediatric patients with psoriasis
    Siegfried, Elaine C.
    Eichenfield, Lawrence F.
    Paller, Amy S.
    Pariser, David
    Creamer, Kara
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (05) : 769 - 774
  • [24] A comprehensive omics assessment of etanercept therapy for psoriasis
    Foulkes, A.
    Rattray, N. J. W.
    Correa, E.
    Trivedi, D. K.
    Carr, D. F.
    Maratou, K.
    Wilson, P.
    Al-Sharqi, A.
    Parslew, R.
    Pirmohamed, M.
    Goodacre, R.
    Reynolds, N.
    Donaldson, M.
    Barnes, M.
    Griffiths, C. E. M.
    Warren, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 : 12 - 12
  • [25] Pharmacogenomic signatures of response to etanercept therapy for psoriasis
    Foulkes, A. C.
    Carr, D. F.
    Al-Sharqi, A.
    Parslew, R.
    Pirmohamed, M.
    Reynolds, N. J.
    Donaldson, M.
    Barnes, M.
    Griffiths, C. E. M.
    Warren, R. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E114 - E115
  • [26] Neutropenia and thrombocytopenia in a patient presenting psoriasis treated with etanercept
    Lahbabi, I.
    Adamski, H.
    Le Jean, S.
    Cannieux, V.
    Polard, E.
    Chevrant-Breton, J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (05): : 409 - 410
  • [27] Acute myelogenous leukemia in a patient receiving etanercept for psoriasis
    Bachmeyer, Claude
    Thioliere, Brigitte
    Khosrotehrani, Kiarash
    Cattan, Elie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (01) : 169 - 170
  • [28] Etanercept-induced leukocytoclastic vasculitis in a patient with psoriasis
    Desai, Nisha
    Stierman, Sarah
    Gottwald, Lorie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB190 - AB190
  • [29] Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept
    Daulat, S.
    Detweiler, J. G.
    Pandya, A. G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (04) : 483 - 484
  • [30] Anal canal adenocarcinoma in a patient with psoriasis treated with etanercept
    Yang, Bei-Bei
    Man, Xiao-Yong
    Zheng, Min
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2016, 82 (01): : 103 - 104
12345